Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.

Hologic’s AI-Powered Mammography Technology “At Hologic, we are constantly pushing ourselves to innovate and enhance the ...

A three-year International Atomic Energy Agency (IAEA) Mammography Project, designed to reduce the burden of breast cancer ...

HOLX's Genius AI Detection flags missed breast cancers, showing promise in improving mammography accuracy and radiologist efficiency.

THE Ministry of Health recently hosted a comprehensive training closing session to mark the ending of a three-year International Atomic Energy Agency (IAEA) ...

A study published in the American Journal of Roentgenology demonstrated the powerful potential of AI-powered mammography, ...

A large observational study using data from the Breast Cancer Surveillance Consortium suggested that supplemental MRI with or without mammography was tied to increased rates of screen-detected ...

Hologic, Inc. (NASDAQ: HOLX), a leading medical technology company dedicated to improving women’s health, today announced new data that highlights how the company’s advanced AI-powered mammography ...

In the realm of medical imaging, mammography stands out as a pivotal tool for detecting breast abnormalities, particularly in the context of breast cancer screening and diagnosis. As the global ...

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling December 3, 2025-- Lunit (KRX:328130), a leading provider of AI for ...

Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker ...